97 related articles for article (PubMed ID: 7514549)
21. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
Kageyama K; Hanada K; Iwasaki Y; Sakihara S; Nigawara T; Kasckow J; Suda T
J Endocrinol; 2007 Nov; 195(2):199-211. PubMed ID: 17951532
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
Coleman DT; Chen X; Sassaroli M; Bancroft C
Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
[TBL] [Abstract][Full Text] [Related]
24. Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone alpha-subunit promoter.
Kay TW; Jameson JL
Mol Endocrinol; 1992 Nov; 6(11):1767-73. PubMed ID: 1282668
[TBL] [Abstract][Full Text] [Related]
25. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
26. Gonadotropin-releasing hormone causes transcriptional stimulation followed by desensitization of the glycoprotein hormone alpha promoter in transfected alpha T3 gonadotrope cells.
Kay TW; Chedrese PJ; Jameson JL
Endocrinology; 1994 Feb; 134(2):568-73. PubMed ID: 7507827
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells.
Chang CH; Chey WY; Braggins L; Coy DH; Chang TM
Am J Physiol; 1996 Sep; 271(3 Pt 1):G516-23. PubMed ID: 8843778
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells.
Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK
J Endocrinol; 1996 May; 149(2):287-95. PubMed ID: 8708540
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase-activating polypeptide stimulates secretion in T84 cells.
Nguyen TD; Heintz GG; Cohn JA
Gastroenterology; 1992 Aug; 103(2):539-44. PubMed ID: 1321772
[TBL] [Abstract][Full Text] [Related]
30. Pituitary adenylate cyclase-activating polypeptide regulates cytosolic Ca2+ in rat gonadotropes and somatotropes through different intracellular mechanisms.
Rawlings SR; Canny BJ; Leong DA
Endocrinology; 1993 Apr; 132(4):1447-52. PubMed ID: 8384987
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
32. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
33. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
[TBL] [Abstract][Full Text] [Related]
34. Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation.
Farini D; Puglianiello A; Mammi C; Siracusa G; Moretti C
Endocrinology; 2003 Apr; 144(4):1631-43. PubMed ID: 12639948
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
37. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
Delporte C; Poloczek P; de Neef P; Vertongen P; Ciccarelli E; Svoboda M; Herchuelz A; Winand J; Robberecht P
Mol Cell Endocrinol; 1995 Jan; 107(1):71-6. PubMed ID: 7796937
[TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate cyclase-activating polypeptide modulates gastric enterochromaffin-like cell proliferation in rats.
Läuffer JM; Modlin IM; Hinoue T; Kidd M; Zhang T; Schmid SW; Tang LH
Gastroenterology; 1999 Mar; 116(3):623-35. PubMed ID: 10029621
[TBL] [Abstract][Full Text] [Related]
39. Pituitary adenyl cyclase-activating peptide: a hypophysiotropic factor that stimulates proopiomelanocortin gene transcription, and proopiomelanocortin-derived peptide secretion in corticotropic cells.
Boutillier AL; Monnier D; Koch B; Loeffler JP
Neuroendocrinology; 1994 Nov; 60(5):493-502. PubMed ID: 7845539
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
